Literature DB >> 2923567

Vitreoperfusion. A new approach to ocular ischemia.

N P Blair1, D S Baker, J P Rhode, M Solomon.   

Abstract

No satisfactory treatment is available to supply the metabolic needs of the retina in vascular occlusion. Consequently, necrosis occurs. We devised vitreoperfusion, a technique of perfusing the vitreous cavity after vitrectomy-lensectomy with selected fluids containing glucose and oxygen. We tested whether vitreoperfusion could protect the retina from severe combined retinal and choroidal ischemia. An intraocular pressure of 170 mm Hg was induced in each eye of nine cats for up to four hours, and simultaneously one eye of each cat underwent vitreoperfusion. After one week, histopathologic examination revealed retinal atrophy and dissolution in untreated eyes but not in eyes treated with vitreoperfusion. To our knowledge, such severe ischemia has never been treated successfully before. Vitreoperfusion is a potential treatment modality in various forms of ocular ischemia. Additional studies are warranted to refine the technique and determine any clinical applicability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923567     DOI: 10.1001/archopht.1989.01070010427039

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Perfluorocarbon-perfused vitrectomy: a new method for vitrectomy--a safety and feasibility study.

Authors:  Hugo Quiroz-Mercado; J Guerrero-Naranjo; R Agurto-Rivera; C Leizaola-Fernández; L Suárez-Tatá; S Murillo-López; G Reategui-Escalante; G García-Aguirre; J Fromow-Guerra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

2.  Vitreal oxygenation in retinal ischemia reperfusion.

Authors:  Walid Abdallah; Hossein Ameri; Ernesto Barron; Gerald J Chader; Elias Greenbaum; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

3.  Intraocular oxygen tension in eyes with proliferative diabetic retinopathy with and without vitreous.

Authors:  N Maeda; Y Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  Transient disappearance of a symptomatic macular hyperfluorescent lesion following vitrectomy: a case report.

Authors:  J T Harriott; S S Schocket; S D Varma
Journal:  Trans Am Ophthalmol Soc       Date:  1993

5.  Ocular oxygen consumption during vitreoperfusion in the cat.

Authors:  N P Blair
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 6.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

7.  Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study.

Authors:  Tom H Williamson; Jas Grewal; Bhaskar Gupta; Bataung Mokete; Morton Lim; Christopher H Fry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-04       Impact factor: 3.117

8.  An immunohistochemical analysis of the neuroprotective effects of memantine, hyperbaric oxygen therapy, and brimonidine after acute ischemia reperfusion injury.

Authors:  Ulviye Yiğit; Serkan Erdenöz; Unal Uslu; Ersin Oba; Alev Cumbul; Halil Cağatay; Samil Aktaş; Emiray Eskicoğlu
Journal:  Mol Vis       Date:  2011-04-26       Impact factor: 2.367

9.  Retinal Oxygen Delivery, Metabolism and Extraction Fraction and Retinal Thickness Immediately Following an Interval of Ophthalmic Vessel Occlusion in Rats.

Authors:  Norman P Blair; Michael R Tan; Anthony E Felder; Mahnaz Shahidi
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

10.  Retinal Oxygen Delivery and Metabolism Response to Hyperoxia During Bilateral Common Carotid Artery Occlusion in Rats.

Authors:  Sophie Leahy; Nathanael Matei; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.